nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2015, 01, v.21 26-28
枯草杆菌二联活菌肠溶胶囊治疗感染性腹泻及对患者血清C反应蛋白的影响
基金项目(Foundation): 首都卫生发展科研专项(2011-7131-01)~~
邮箱(Email):
DOI: 10.13210/j.cnki.jhmu.20141028.017
发布时间: 2014-10-28
出版时间: 2014-10-28
网络发布时间: 2014-10-28
移动端阅读
摘要:

目的:探讨枯草杆菌二联活菌肠溶胶囊治疗感染性腹泻的疗效及对患者血清C反应蛋白(CRP)的影响。方法:在本院接受治疗的感染性腹泻患者130例,随机分成对照组和观察组,各65例。对照组:甲磺酸左氧氟沙星治疗。观察组:给予甲磺酸左氧氟沙星治疗,并应用枯草杆菌二联活菌肠溶胶囊口服治疗。结果:观察组总有效率高于对照组,差异具有统计学意义(P<0.01)。治疗后3、7、10d,观察组CRP、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平低于对照组,差异具有统计学意义(P<0.01)。观察组腹痛症状消失时间、腹泻症状消失时间以及体温恢复正常的时间均少于对照组,差异具有统计学意义(P<0.01)。结论:枯草杆菌二联活菌肠溶胶囊治疗感染性腹泻疗效显著,能有效缓解患者炎症反应,提高机体免疫力,促进患者症状的缓解。

Abstract:

Objective:To investigate the effects of combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules for infectious diarrhea and its influence on serum C reaction protein.Methods:A total of 130 cases of infectious diarrhea treated in our hospital were randomly divided into control group and observation group with 65 cases in each.Control group was treated with Pefloxacin mesylate.The observation group was treated with Pefloxacin mesylate and the application of combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules oral.Results:The total efficiency of the observation group was 96.92% higher than that of the control group(81.54%),the difference was statistically significant(P<0.01).After 3,7,10 dof treatment,CRP,TNF-α,IL-6levels of the observation group was lower than that of the control group,the difference was statistically significant(P<0.01).The symptoms of abdominal pain,diarrhea symptoms disappear time,body temperature returned to normal time of the observation group were less than that of the control group showing with statistically significant difference(P<0.01).Conclusion:Combined use of Bacillus subtilis and Enterococcus faecium enteric-coated capsules is effective on infectious diarrhea,it can effectively alleviate the inflammatory reaction,improve immunity,promote the remission of symptoms.

参考文献

1 张庆惠.2005-2012年沈阳市和平区其他感染性腹泻病流行特征分析[J].职业与健康,2014,30(3):373-374.

2 Scharf RJ,Deboer MD,Guerrant RL,Recent advances in understanding the long-term sequelae of childhood infectious diarrhea[J].Current infectious disease reports,2014,16(6):408.

3 黎媛,刘晓君,邓燕.消旋卡多曲治疗小儿秋季腹泻的疗效及对C反应蛋白的影响[J].中国基层医药,2013,20(18):2825-2827.

4 李烨,刘艳红.左氧氟沙星治疗急性重症细菌性感染性腹泻的临床分析[J].吉林医学,2014,35(12):2552.

5 白乌日娜,蒋琳,计春燕,等.粪钙卫蛋白测定判断感染性腹泻的临床价值[J].胃肠病学和肝病学杂志,2011,20(05):453-455.

6 Levine MM,Robins-Browne RM.Factors that explain excretion of enteric pathogens by persons without diarrhea[J].Clin Infect Dis,2012,55(4):S303-311.

7 王波,徐家丽.小儿感染性腹泻血CRP和WBC计数、N%变化的比较分析[J].中华全科医学,2013,11(02):246-248.

8 赵琪彦,王培昌.成人急性腹泻患者血常规和C反应蛋白变化及意义[J].中华实用诊断与治疗杂志,2012,26(02):145-146.

9 田景波,曲燕,朱文娣,等.复合乳酸菌胶囊联合左氧氟沙星治疗急性细菌性腹泻效果观察[J].中国医药,2013,8(09):1262-1263.

10 Liu HX,Zhang J.Analysis of reported infectious diarrhea(other than cholera,dysentery,typhoid and paratyphoid)in China in2011[J].Chinese journal of preventive medicine,2013,47(4):328-332.

11 董文珠,吴晓青,杨凌辉,等.认知治疗联合益生菌、匹维溴胺治疗腹泻型肠易激综合征的临床研究[J].胃肠病学和肝病学杂志,2012,21(9):861-864.

12 黄烈华,孙薇薇.锌制剂对小儿腹泻病患者红细胞免疫及细胞免疫的影响研究[J].海南医学院学报,2013,19(1):104-106.

13 吴立新,张声生.双歧杆菌四联活菌片联合用药对小儿非感染性腹泻的疗效及血清中IL-6、IL-17表达影响研究[J].重庆医学,2013,42(15):1703-1705.

14 杨磊,袁星星,李莹,等.枯草杆菌二联活菌肠溶胶囊结合马来酸曲美布汀治疗功能性腹泻的临床疗效观察[J].中国中西医结合消化杂志,2014,22(6):297-299.

15 姜小龙.美沙拉嗪与枯草杆菌二联活菌肠溶胶囊联用治疗溃疡性结肠炎疗效探讨[J].中国药物与临床,2013,13(3):386-387.

16 韦明,李宏.硫酸依替米星联合枯草杆菌二联活菌肠溶胶囊治疗细菌性腹泻疗效观察[J].安徽医学,2012,33(4):470-471.

基本信息:

DOI:10.13210/j.cnki.jhmu.20141028.017

中图分类号:R574.62

引用信息:

[1]何梅英,徐光耀,贾秀平.枯草杆菌二联活菌肠溶胶囊治疗感染性腹泻及对患者血清C反应蛋白的影响[J].海南医学院学报,2015,21(01):26-28.DOI:10.13210/j.cnki.jhmu.20141028.017.

基金信息:

首都卫生发展科研专项(2011-7131-01)~~

发布时间:

2014-10-28

出版时间:

2014-10-28

网络发布时间:

2014-10-28

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文